These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 29073272)
1. Highly aggressive rat prostate tumors rapidly precondition regional lymph nodes for subsequent metastatic growth. Strömvall K; Lundholm M; Thysell E; Bergh A; Halin Bergström S PLoS One; 2017; 12(10):e0187086. PubMed ID: 29073272 [TBL] [Abstract][Full Text] [Related]
2. Aggressive rat prostate tumors reprogram the benign parts of the prostate and regional lymph nodes prior to metastasis. Strömvall K; Thysell E; Halin Bergström S; Bergh A PLoS One; 2017; 12(5):e0176679. PubMed ID: 28472073 [TBL] [Abstract][Full Text] [Related]
3. Reduced number of CD169 Strömvall K; Sundkvist K; Ljungberg B; Halin Bergström S; Bergh A Prostate; 2017 Nov; 77(15):1468-1477. PubMed ID: 28880401 [TBL] [Abstract][Full Text] [Related]
4. Extracellular Vesicles from Metastatic Rat Prostate Tumors Prime the Normal Prostate Tissue to Facilitate Tumor Growth. Halin Bergström S; Hägglöf C; Thysell E; Bergh A; Wikström P; Lundholm M Sci Rep; 2016 Aug; 6():31805. PubMed ID: 27550147 [TBL] [Abstract][Full Text] [Related]
5. Rat prostate tumors induce DNA synthesis in remote organs. Halin Bergström S; Lundholm M; Nordstrand A; Bergh A Sci Rep; 2022 May; 12(1):7908. PubMed ID: 35551231 [TBL] [Abstract][Full Text] [Related]
7. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis. Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000 [TBL] [Abstract][Full Text] [Related]
8. Orthotopic treatment model of prostate cancer and metastasis in the immunocompetent mouse: efficacy of flt3 ligand immunotherapy. Somers KD; Brown RR; Holterman DA; Yousefieh N; Glass WF; Wright GL; Schellhammer PF; Qian J; Ciavarra RP Int J Cancer; 2003 Dec; 107(5):773-80. PubMed ID: 14566827 [TBL] [Abstract][Full Text] [Related]
9. Systemic interleukin 2 therapy for human prostate tumors in a nude mouse model. Triest JA; Grignon DJ; Cher ML; Kocheril SV; Montecillo EJ; Talati B; Tekyi-Mensah S; Pontes JE; Hillman GG Clin Cancer Res; 1998 Aug; 4(8):2009-14. PubMed ID: 9717832 [TBL] [Abstract][Full Text] [Related]
10. Prostate stem cell antigen is overexpressed in prostate cancer metastases. Lam JS; Yamashiro J; Shintaku IP; Vessella RL; Jenkins RB; Horvath S; Said JW; Reiter RE Clin Cancer Res; 2005 Apr; 11(7):2591-6. PubMed ID: 15814638 [TBL] [Abstract][Full Text] [Related]
11. Longitudinal 3.0T MRI analysis of changes in lymph node volume and apparent diffusion coefficient in an experimental animal model of metastatic and hyperplastic lymph nodes. Klerkx WM; Geldof AA; Heintz AP; van Diest PJ; Visser F; Mali WP; Veldhuis WB J Magn Reson Imaging; 2011 May; 33(5):1151-9. PubMed ID: 21509874 [TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta 1 overproduction in prostate cancer: effects on growth in vivo and in vitro. Steiner MS; Barrack ER Mol Endocrinol; 1992 Jan; 6(1):15-25. PubMed ID: 1738367 [TBL] [Abstract][Full Text] [Related]
13. Prediction of immune surveillance responsive metastatic prostate cancer in pelvic lymph node and emergence of surveillance unresponsive/resistant metastatic cells. Sinha AA; Fernandes ET; Ewing SL; Wilson MJ Anticancer Res; 2013 Sep; 33(9):3635-43. PubMed ID: 24023290 [TBL] [Abstract][Full Text] [Related]
14. Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model. Kovar JL; Johnson MA; Volcheck WM; Chen J; Simpson MA Am J Pathol; 2006 Oct; 169(4):1415-26. PubMed ID: 17003496 [TBL] [Abstract][Full Text] [Related]
15. Traffic to lymph nodes of PC-3 prostate tumor cells in nude mice visualized using the luciferase gene as a tumor cell marker. Rubio N; Villacampa MM; Blanco J Lab Invest; 1998 Oct; 78(10):1315-25. PubMed ID: 9800957 [TBL] [Abstract][Full Text] [Related]
16. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Pettaway CA; Pathak S; Greene G; Ramirez E; Wilson MR; Killion JJ; Fidler IJ Clin Cancer Res; 1996 Sep; 2(9):1627-36. PubMed ID: 9816342 [TBL] [Abstract][Full Text] [Related]
17. Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction. Deguchi T; Doi T; Ehara H; Ito S; Takahashi Y; Nishino Y; Fujihiro S; Kawamura T; Komeda H; Horie M Cancer Res; 1993 Nov; 53(22):5350-4. PubMed ID: 7693338 [TBL] [Abstract][Full Text] [Related]
18. Number of metastatic lymph nodes as determinant of outcome after salvage radical prostatectomy for radiation-recurrent prostate cancer. Gugliemetti G; Sukhu R; Conca Baenas MA; Meeks J; Sjoberg DD; Eastham JA; Scardino PT; Touijer K Actas Urol Esp; 2016 Sep; 40(7):434-9. PubMed ID: 27184342 [TBL] [Abstract][Full Text] [Related]
19. Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis. Burton JB; Priceman SJ; Sung JL; Brakenhielm E; An DS; Pytowski B; Alitalo K; Wu L Cancer Res; 2008 Oct; 68(19):7828-37. PubMed ID: 18829538 [TBL] [Abstract][Full Text] [Related]